JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 11, 2005; DOI: 10.1124/jpet.105.084152


0022-3565/05/3133-1387-1396$20.00
JPET 313:1387-1396, 2005
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.084152v1
313/3/1387    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, H.
Right arrow Articles by Cuevas, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, H.
Right arrow Articles by Cuevas, J.

NEUROPHARMACOLOGY

{sigma} Receptor Activation Blocks Potassium Channels and Depresses Neuroexcitability in Rat Intracardiac Neurons

Hongling Zhang, and Javier Cuevas

Department of Pharmacology and Therapeutics, University of South Florida College of Medicine, Tampa, Florida

Received January 26, 2005; accepted March 8, 2005.


    Abstract
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
The {sigma} receptors have been implicated in the regulation of the cardiovascular system, and {sigma}-1 receptor transcripts have been found in parasympathetic intracardiac neurons. However, the cellular function of {sigma}-1 receptors in these cells remains to be determined. Effects of {sigma} receptor activation on voltage-activated K+ channels and action potential firing were studied in isolated intracardiac neurons using whole-cell patch-clamp recording techniques. Activation of {sigma} receptors reversibly blocked delayed outwardly rectifying potassium channels, large conductance Ca2+-sensitive K+ channels, and the M-current with maximal inhibition >80%. The inhibition of K+ channels by {sigma} ligands was dose-dependent, and the rank order potency of (+)-pentazocine > ibogaine > 1,3-di-O-tolyguanidin (DTG) suggests that the effect is mediated by {sigma}-1 receptor activation. Preincubation of neurons with the irreversible {sigma} receptor antagonist metaphit blocked DTG-induced inhibition of K+ channels, confirming that the effect is mediated by {sigma} receptor activation. Although bath application of {sigma} ligands depolarized intracardiac neurons, the number of action potentials fired by the cells in response to depolarizing current pulses was decreased in the presence of these drugs. Neither dialysis of the neurons nor application of intracellular 5'-O-(2-thiodiphosphate) trilithium salt inhibited the effect of {sigma} receptors on K+ channels, which suggests that the signal transduction pathway does not involve a diffusible cytosolic second messenger or a G protein. Together, these data suggest that {sigma}-1 receptors are directly coupled to K+ channels in intracardiac neurons. Furthermore, activation of {sigma}-1 receptors depresses the excitability of intracardiac neurons and is thus likely to block parasympathetic input to the heart.


The {sigma} receptors are nonopioid, nonphencyclidine receptors that are distributed throughout the central and peripheral nervous system. These receptors have high affinity for numerous drugs in clinical use, including psychotherapeutic agents such as antipsychotics (Su, 1982Go) and selective serotonin reuptake inhibitors (Narita et al., 1996Go). At least two subtypes of {sigma} receptors have been classified based on the findings from biochemical and radioligand binding experiments, and they have been designated as {sigma}-1 and {sigma}-2 (Hellewell and Bowen,1990Go). However, to date, only the {sigma}-1 receptor has been cloned (Hanner et al., 1996Go). These receptors have been implicated in physiological processes such as learning and memory and in pathophysiological disorders such as schizophrenia and depression (Snyder and Largent, 1989Go). More recently, {sigma} receptors have been linked to the development of drug dependence (Ujike et al., 1996Go).

The {sigma} receptors also seem to play a role in the regulation of the cardiovascular system, as suggested by pharmacological studies using {sigma} receptor ligands. For example, it has been shown that the {sigma} receptor ligand DuP 754 raises the threshold of ventricular fibrillation in rats (Lishmanov et al., 1999Go). Conversely, the {sigma} receptor agonists (+)-SKF-10,047, 1,3-di-O-tolyguanidin (DTG), and (+)-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine have been shown to produce tachycardia by activating central and peripheral {sigma} receptors (Wu and Martin, 1989Go; Lishmanov et al., 2000Go). Some of the effects of {sigma} receptor ligands on the cardiovascular system are likely due to activation of {sigma} receptors on cardiac muscle. The {sigma} receptors have been detected in cardiac myocytes from neonatal and adult rats, and stimulation of these receptors was shown to elicit direct inotropic and chronotropic effects on cardiac muscle (Ela et al., 1994Go; Novakova et al., 1995Go). However, {sigma} receptors have also been found in autonomic neurons that regulate the cardiovascular system (Zhang and Cuevas, 2002Go), and modulation of the electrical activity of these neurons by endogenous or exogenous {sigma} ligands is likely to have profound effects on cardiovascular function.

The {sigma} receptor ligands, including haloperidol, (+)-pentazocine, DTG, and ibogaine, were previously shown to inhibit high-voltage-activated calcium channels in intrinsic cardiac neurons (Zhang and Cuevas, 2002Go). The pharmacological profile of the {sigma} receptor mediating these effects was consistent with a {sigma}-2 receptor. Although {sigma}-1 receptor transcripts were detected in intracardiac neurons, no cellular effects have been attributed to this receptor. One possible role for {sigma}-1 receptors in these cells is the modulation of voltage-activated K+ channels. Recent experiments have shown that currents mediated by Kv1.4 and Kv1.5 are depressed by the {sigma} ligand (+)-SKF-10,047 in oocytes injected with Kv subunits and the {sigma}-1 receptor but not in oocytes injected with the Kv subunits alone (Aydar et al., 2002Go). Furthermore, {sigma}-1 receptors were shown to alter the kinetic properties of Kv1.4 channels in the absence of ligand, and Kv1.4 and Kv1.5 coimmunoprecipitated with the {sigma}-1 receptor (Aydar et al., 2002Go), which led those investigators to propose that the {sigma}-1 receptor functions as a ligand-regulated auxiliary K+ channel subunit. The inhibition of delayed outwardly rectifying K+ channels, such as Kv1.5, by verapamil has been shown to depress action potential firing in intrinsic cardiac neurons, and this phenomenon has been implicated in the tachycardia associated with this type IV antiarrhythmic drug (Hogg et al., 1999Go). However, it remains to be determined whether {sigma}-1 receptors couple to voltage-activated K+ channels in intracardiac neurons, and whether {sigma} receptor activation can alter the active membrane proprieties of these cells. By regulating the function of K+ channels in parasympathetic intracardiac neurons, {sigma}-1 receptors, and therefore drugs that act on these receptors, may have significant influence on the heart.

Experiments were undertaken to determine the effects of {sigma} receptors on currents mediated by voltage-activated K+ channels (IK) and the active membrane properties of intracardiac neurons from neonatal rats. The {sigma} receptors were shown to decrease the peak amplitude of currents mediated by delayed outwardly rectifying K+ channels [IK(DR)], large conductance Ca2+-sensitive K+ channels (IBK), and the M-current (IM). The rank-order potency of K+ channel inhibition by different {sigma} ligands suggest that the effect is mediated by {sigma}-1 receptors. Neither cell dialysis nor intracellular application of guanosine 5'-O-(2-thiodiphosphate) trilithium salt (GDP-{beta}-S) blocked the effects of {sigma}-1 receptors on IK, consistent with a direct interaction between {sigma}-1 receptors and the K+ channels. Activation of {sigma}-1 receptors also decreased action potential firing and changed the action potential configuration in intracardiac neurons. Therefore, {sigma}-1 receptor activation depresses the excitability of intracardiac neurons and is likely to attenuate parasympathetic input to the heart.


    Materials and Methods
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Preparation. The isolation and culture of neurons from neonatal rat intracardiac ganglia has been described previously (Cuevas and Adams, 1994Go). Briefly, neonatal rats (2–7 days old) were euthanized by decapitation, and the hearts were excised and placed in a physiological saline solution containing 140 mM NaCl, 3 mM KCl, 2.5 mM CaCl2, 0.6 mM MgCl2, 7.7 mM glucose, and 10 mM histidine, pH to 7.2 with NaOH. Atria were removed and incubated for 1 h at 37°C in physiological saline solution containing 1 mg/ml collagenase (type 2, Worthington Biochemicals, Freehold, NJ). After enzymatic treatment, clusters of ganglia were dissected from the epicardial ganglion plexus and dispersed by trituration in a high-glucose culture medium (Dulbecco's modified Eagle's medium), 10% fetal calf serum, 100 units/ml penicillin, and 0.1 mg/ml streptomycin. The dissociated neurons were then plated onto glass coverslips coated with poly-L-lysine and incubated at 37°C under a 95% air/5% CO2 atmosphere for 48 to 72 h.

Electrical Recordings. Electrophysiological recording methods used were similar to those described previously (Cuevas et al., 1997Go). Active membrane properties and voltage-activated K+ channel currents in intracardiac neurons were studied under current-clamp and voltage-clamp mode, respectively, using the whole cell patch-clamp technique. Electrical access was achieved through the use of the amphotericin B perforated-patch method to preserve the intracellular integrity and prevent the loss of cytoplasmic components and subsequent alteration of the functional responses of these neurons (Cuevas and Adams, 1994Go). For perforated patch experiments, a stock solution of 60 mg/ml amphotericin B in dimethyl sulfoxide was prepared and diluted in pipette solution immediately before use to yield a final concentration of 198 µg/ml amphotericin B in 0.33% dimethyl sulfoxide. Final patch pipette resistance was 1.0 to 1.3 M{Omega} to permit maximal electrical access under the present recording configuration.

Action potentials were elicited by depolarizing current pulses (+100 pA) in absence and presence of {sigma} ligands. Currents through depolarization-activated K+ channels were elicited by step depolarizations from –90 mV to more positive potentials (-50 to +70 mV). For experiments studying the effects of {sigma} receptor activation on IM, cells were held at -30 mV to activate the channel and repolarized to -60 mV to deactivate the channels. Membrane voltages and currents were amplified using an Axopatch 200B patch-clamp amplifier (Axon Instruments, Inc., Union City, CA), filtered at 5 kHz (-3 dB; four-pole Bessel filter), and digitized at 20 kHz (Digidata 1200B).

Data Analysis. Analyses of these data were conducted using the SigmaPlot 2000 program (SPSS Inc., Chicago, IL). Data points represent means ± S.E.M. Statistical difference was determined using paired t test for within-group experiments and unpaired t test for between groups experiments and was considered significant if p < 0.05.

Solutions and Reagents. The bath solution for action potential experiments was a physiological saline solution (PSS) containing 140 mM NaCl, 1.2 mM MgCl2, 3 mM KCl, 2.5 mM CaCl2, 7.7 mM glucose, and 10 mM HEPES, pH to 7.2 with NaOH. Potassium channel currents were isolated by adding tetrodotoxin (TTX; 400 nM) and cadmium chloride (CdCl2; 100 µM) to the PSS to inhibit voltage-activated Na+ channel and Ca2+ channel currents, respectively. Pipette solution used for perforated patch experiments contained 75 mM K2SO4, 55 mM KCl, 5 mM MgSO4, and 10 mM HEPES (adjust to pH 7.2 with N-methyl-D-glucamine). For studies using conventional (dialyzing) whole cell recording configuration, the pipette solution contained140 mM KCl, 2 mM MgCl2, 2 mM EGTA, 2 mM Mg2ATP, 0.1 mM GTP lithium salt (GTP), and 10 mM HEPES-KOH, pH to 7.2. In some experiments, GTP was replaced with 100 µM GDP-{beta}-S to inhibit G protein activation. All chemical reagents used were of analytical grade. Haloperidol, ibogaine hydrochloride, (+)-pentazocine, DTG, (+)-SKF-10,047, TTX; tetraethylammonium chloride (TEA), and linopirdine were purchased from Sigma-Aldrich (St. Louis, MO).


    Results
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
{sigma} Receptor Activation Inhibits Delayed Outward Rectifying K+ Currents. Mammalian intracardiac neurons exhibit currents mediated by delayed outwardly rectifying K+ channels (Xi-Moy and Dun, 1995Go; Hogg et al., 1999Go) and express various subunits that contribute to these channels, including KCNA5 and KCNA6 (J. Cuevas, unpublished observation). Given that {sigma}-1 receptors have been shown to depress heterologously expressed KCNA5 channels (Aydar et al., 2002Go) and that inhibition of these channels may have significant effects on the function of intracardiac neurons, it seemed prudent to test the effects of {sigma} receptor activation on currents mediated by voltage-activated K+ channels in these cells. Figure 1A shows a family of depolarization-activated K+ currents recorded from a single intracardiac neuron in the absence and presence of 100 µM DTG. Bath application of 100 µM DTG depressed peak voltage-activated K+ current amplitude at potentials positive to +20 mV. The voltage dependence and kinetics of the currents observed are consistent with the delayed outwardly rectifying K+ current [IK(DR)] previously reported in intracardiac neurons (Xi-Moy and Dun, 1995Go). Figure 1B shows a plot of the mean peak IK(DR) amplitude in the absence and presence of DTG as a function of voltage. The DTG-induced block of IK(DR) was voltage-dependent, with the current being blocked by 26.5 ± 6.2% at +70 mV but only by 1.5 ± 0.1% at +10 mV (n = 7). This difference was statistically significant (p < 0.01).



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 1. The {sigma} receptor ligands inhibit IK(DR) in rat intracardiac neurons. A, depolarization-activated (-50 to +70 mV; 300 ms) K+ currents recorded from a single neuron held at -90 mV in the absence (control) and presence of 100 µM DTG (DTG) or after washout of drug (wash). B, peak IK(DR) current density as a function of voltage recorded in a similar manner from seven neurons in the absence ({circ}) and presence ({bullet}) of 100 µM DTG.

 
Concentration-Dependent Inhibition of IK(DR) by {sigma} Ligands. Further pharmacological experiments were undertaken to confirm that {sigma} receptors inhibit IK(DR) in intracardiac neurons and to identify the {sigma} receptor subtype mediating the observed effects. Figure 2A shows representative currents recorded from three intracardiac neurons in the absence (control) and presence of (+)-pentazocine, ibogaine, and DTG, respectively, at the indicated concentrations. All of the {sigma} ligands tested depressed peak IK(DR) in a concentration-dependent manner. A plot of the mean peak IK(DR) as a function of drug concentration for several {sigma} ligands is shown in Fig. 2B. Fits of the data using the Hill equation gave half-maximal inhibitory concentration (IC50) values for haloperidol, (+)-pentazocine, ibogaine, (+)-SKF-10,047, and DTG of 9.7 ± 0.5, 76.4 ± 7.7, 218.1 ± 7.0, 295.4 ± 45.4, and 341.3 ± 26.0 µM, respectively, and Hill coefficients of ~0.9 for all drugs. Maximum inhibition of IK(DR) by {sigma} ligands was more than 80%. The IC50 values and rank-order potency, in particular the observation that (+)-pentazocine is significantly more potent than ibogaine (p < 0.001), suggests that the effect on IK(DR) is mediated by activation of {sigma}-1 receptors.



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2. Dose-dependent inhibition of IK(DR) by {sigma} receptor ligands in rat intracardiac neurons. A, whole cell K+ currents evoked from three intracardiac neuron by step depolarizations to +50 mV from a holding potential of -90 mV in the absence (control) and presence of (+)-pentazocine, ibogaine, and DTG at the indicated concentrations. B, peak whole cell IK(DR) current amplitude, evoked by depolarizing to +50 mV from -90 mV, normalized to control, and plotted as a function of {sigma} ligands concentration. Data points represent mean ± S.E.M. for four or more observations. The curves represent best fit to the data using the Hill equation. Half-maximal inhibition was 9.7 ± 0.5 µM for haloperidol, 76.4 ± 7.7 µM for (+)-pentazocine, 218.1 ± 7.0 µM for ibogaine, 295.4 ± 45.4 µM for (+)-SKF-10,047, and 341.3 ± 26.0 µM for DTG. The corresponding Hill coefficients were 1.01 ± 0.05, 0.69 ± 0.05, 1.14 ± 0.04, 0.84 ± 0.11, and 0.97 ± 0.07, respectively.

 
The {sigma} Receptor Antagonist Metaphit Depresses the Effect of DTG on K+ Channels. To confirm the fact that the effect of {sigma} ligands on IK(DR) was mediated by activation of {sigma} receptors and not the result of direct channel block, experiments were done using the irreversible {sigma} receptor antagonist metaphit. Metaphit rapidly and specifically acetylates {sigma} receptors and inhibits ligand binding to the receptor (Bluth et al., 1989Go). In intracardiac neurons, metaphit has been shown to block {sigma}-2 receptor-mediated attenuation of voltagegated Ca2+ channel currents (Zhang and Cuevas, 2002Go). Isolated intracardiac neurons were preincubated in 50 µM metaphit (in PSS) for 10 min at room temperature. After washout of drug, IK(DR) was activated by depolarizing cells to +50 mV from a holding potential of -90 mV in the absence and presence of 100 µM DTG. Figure 3A shows representative currents recorded from two different intracardiac neurons without (top) or with (bottom) metaphit preincubation. Upon application of DTG, IK(DR) peak amplitude was depressed under both conditions, but in cells preincubated in metaphit the response to DTG was obtunded. Figure 3B shows a bar graph of degree of block of IK(DR) by 100 µM DTG in control neurons (DTG; n = 4) or neurons preincubated in metaphit (metaphit + DTG; n = 5). DTG decreased mean IK(DR) by 31 ± 3% in control cells, whereas in cells exposed to metaphit the decrease was 18 ± 3%. The difference in DTG attenuation of IK(DR) for the two conditions was statistically significant (p < 0.05). Several other {sigma} receptor antagonists, including SM-21, BD-1047, and BD-1063 were tested to determine whether these agents could block the effects of DTG on IK(DR). However, all of these drugs themselves depressed peak amplitude of IK(DR), suggesting that they are either acting as partial agonists of the {sigma}-1 receptors, as reported previously for BD-1047 (Zambon et al., 1997Go), or having direct effects on the K+ channels.



View larger version (10K):
[in this window]
[in a new window]
 
Fig. 3. Attenuation of DTG-mediated inhibition of IK(DR) by the {sigma} receptor antagonist metaphit. A, depolarization-activated (-90 to 50 mV) IK(DR) recorded from two intracardiac neurons in the absence (control) and presence of 100 µM DTG (DTG). Bottom traces are from a neuron preincubated in metaphit (50 µM in PSS, 10 min). B, bar graph of the percent inhibition of mean peak IK(DR) (±S.E.) produced by 100 µM DTG in control cells that were not exposed to metaphit (DTG) or cells preincubated in metaphit (50 µM; 10 min; metaphit + DTG). IK(DR) was evoked by step depolarizations (-90 to +50 mV). Data were collected from seven neurons for each condition, and the asterisk denotes significant difference between the groups (p < 0.05).

 

Effect of Intracellular Dialysis with GTP and GDP-{beta}-S on {sigma} Receptor Inhibition of IK(DR). Controversy exists in the literature as to whether {sigma} receptors couple to G proteins and whether these second messengers are involved in the regulation of ion channels by {sigma} receptors. To determine whether {sigma} receptor-mediated inhibition of K+ channels in intrinsic cardiac neurons is dependent on G protein activation, neurons were dialyzed with pipette solution containing either 100 µM GTP or the G protein inhibitor GDP-{beta}-S (100 µM). Cell dialysis with 100 µM GDP-{beta}-S has previously been shown to successfully block G protein-mediated signal transduction in intrinsic cardiac neurons (Cuevas and Adams, 1994Go, 1997Go; Zhang and Cuevas, 2002Go). Figure 4A shows representative currents in response to step depolarizations from -90 to +50 mV recorded from two neurons dialyzed with either GTP (top traces) or GDP-{beta}-S (bottom traces) in the absence and presence of 100 µM DTG. The inhibition of IK(DR) evoked by this concentration of DTG under dialyzing conditions, with GTP in the pipette, was similar to that observed when the intracellular milieu was preserved (~30%). The DTG-induced attenuation of IK(DR) was present when the cells were dialyzed with GDP-{beta}-S (Fig. 4A, bottom traces). A summary of the peak IK(DR) amplitudes elicited upon depolarization to +50 mV under the different experimental conditions and normalized to their respective control values is presented in Fig. 4B. The difference observed between the two groups was not statistical significant. The current-voltage relationships for six neurons dialyzed with either GTP or GDP-{beta}-S are shown in Fig. 4, C and D, respectively. Whereas dialyzing cells with GDP-{beta}-S decreased the peak IK(DR) amplitude, compared with the cells dialyzed with GTP, DTG attenuated peak amplitudes under both conditions to a similar extent. These data suggest that neither cell dialysis nor inhibition of G protein activation blocks {sigma}-1 receptor-mediated inhibition of IK(DR). Thus, neither a diffusible cytosolic second messenger nor a G protein couples {sigma}-1 receptors to IK(DR).



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4. The {sigma} receptor inhibition of IK(DR) is not blocked by intracellular GDP-{beta}-S. A, depolarization activate (-90 to +50 mV) K+ currents recorded from neurons dialyzed with pipette solutions containing either 100 µM GTP or GDP-{beta}-S in the absence (control) or presence of 100 µM DTG (DTG). B, mean (±S.E.M.) peak IK(DR) recorded from neurons dialyzed with either GTP (n = 6) or GDP-{beta}-S (n = 6) in the presence of 100 µM DTG. Currents are normalized to their respective controls (absence of drug). Mean (±S.E.) peak IK(DR) current density as a function of depolarization voltage (-90-mV holding potential) recorded from neurons dialyzed with pipette solution containing either 100 µM GTP (C; n = 6) or 100 µM GDP-{beta}-S (D; n = 6) in the absence ({circ}) and presence ({bullet}) of 100 µM DTG.

 

Effects of {sigma} Receptor Ligands on Action Potential Firing. Studies have shown that inhibition of IK(DR) by verapamil in intracardiac neurons can depress action potential firing (Hogg et al., 1999Go). Experiments were thus conducted to determine whether {sigma} receptor modulation IK(DR) has a similar effect on neuroexcitability in these cells. The effects of {sigma} ligands on the active membrane properties of isolated intracardiac neurons were studied using the amphotericin B perforated patch method under current-clamp mode. Figure 5A shows a family of action potentials elicited from a single intracardiac neuron in response to depolarizing current pulses (100 pA; 400 ms) in the absence (control) and presence of 100 µM DTG (DTG), and after washout of drug (wash). DTG depolarized the neuron and decreased the number of action potentials evoked by the current injection in a rapidly reversible manner. In similar experiments, 100 µM DTG depolarized neurons from a control value of -50.8 ± 2.1 to -49.2 ± 2.4 mV (n = 9). DTG also decreased the number of action potentials evoked by depolarizing membrane pulses by 85% (Fig. 5B). Both of these changes were statistically significant (p < 0.01 and p < 0.001, respectively). DTG also altered the action potential configuration by decreasing both the action potential overshoot and afterhyperpolarization (AHP) and by slowing both the rate of depolarization and rate of repolarization (Fig. 5A, inset; Table 1). The effects of DTG were mimicked by 10 µM haloperidol, 200 µM ibogaine, and 50 µM (+)-pentazocine, which depressed action potential firing by 65, 85, and 65%, respectively and changed the configurations of the waveform in a reversible manner. The effects of the {sigma} ligands on the action potential firing and configuration are summarized in Table 1.



View larger version (15K):
[in this window]
[in a new window]
 
Fig. 5. Inhibition of action potential firing by {sigma} receptor ligand DTG in rat intracardiac neurons. A, action potentials fired from an isolated intracardiac neuron in response to 100-pA depolarizing current pulses in the absence (control) and presence of 50 µM DTG (DTG) and following washout of drug (wash). Inset is superimposition of first action potential from control and DTG traces. B, bar graph of the number of action potentials fired in the absence (control) or presence of 100 µM DTG (DTG) and after washout of the drug (wash). Asterisk denotes significant difference from control and DTG (p < 0.01) (n = 7).

 

View this table:
[in this window]
[in a new window]
 
TABLE 1 Effects of {sigma} ligands on the resting membrane potential and action potential waveform parameters Action potentials were evoked by 100-pA current injections. All drugs were bath applied, and the data are shown as mean ± S.E. for the number of cells (n) shown in the table.

 

Role of M-Currents in the Effects of {sigma} Receptor Activation. One possible mechanism by which {sigma}-1 receptor activation depolarizes intracardiac neurons is via a block of the M-current. Previous studies have shown that inhibition of IM by muscarinic receptor activation depolarizes intracardiac neurons (Cuevas et al., 1997Go). The M-channels mediating IM are noninactivating and close slowly in response to membrane repolarization from depolarizing holding potentials. The closing of these channels in intracardiac neurons upon repolarization results in a characteristic inward current relaxation (Cuevas et al., 1997Go). Figure 6A shows whole cell currents recorded from a single cell in response to repolarizing steps to -60 mV from a holding potential of -30 mV in the absence (control) and presence of 1 mM DTG. The inward relaxation observed under control conditions is abolished by application of DTG. Similarly, 20 µM linopirdine, a specific blocker of IM (Wallace et al., 2002Go), eliminates the inward relaxation (Fig. 6B). Figure 6, C and D, shows bar graphs of mean peak IM recorded under control conditions (absence of drug) and when either DTG (n = 4) or linopirdine (n = 6) was added, respectively. IM was completely blocked by application of either drug, and this effect was reversible after washout in both cases (data not shown).



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 6. The {sigma} receptor ligand DTG inhibits the M-current in rat intracardiac neurons. A, slow inward current relaxation (M-current) induced by repolarizing step (-30 to -60 mV; 250 ms) recorded from a single intracardiac neuron before (control) and after application of 1 mM DTG (DTG). B, M-current recorded in the absence (control) and in the presence of 20 µM linopirdine (linopirdine). Bar graph of mean current amplitudes in the absence (control) or presence of 1 mM DTG (C; n = 4) and 20 µM linopirdine (D; n = 6). The amplitude of the M-current was defined as the difference between the peak current observed at the start of the relaxation (A, left trace, black arrow) and the holding current at the end of the 250-ms repolarizing step (A, left trace, gray arrow). Asterisks denote significant difference from control (p < 0.001).

 
Effects of {sigma} Receptor Activation on BK Currents. In central and peripheral neurons, action potential AHPs are mediated by the opening of Ca2+-activated K+ channels [IK(Ca)]. Thus far, three types of Ca2+-activated K+ channels have been identified on the basis of their pharmacology and single channel conductances. These channels have been named according to their unitary conductance: large (big) conductance K(Ca) channels (BK), small conductance K(Ca) channels (SK), and intermediate conductance (IK). Although both BK and SK channels have been found in mammalian intracardiac neurons, neonatal rat intracardiac neurons only express BK channels (Franciolini et al., 2001Go; Jelson et al., 2003Go). The fact that {sigma} receptor activation decreases the AHP suggests that {sigma} receptors may modulate these channels. TEA, at micromolar concentrations (200–500 µM), has been shown to preferentially block BK channels in intracardiac neurons and to block the AHPs more effectively than either charybdotoxin or iberiotoxin (Franciolini et al., 2001Go). Thus, 500 µM TEA was used to distinguish between outward K+ currents mediated by BK and other K+ channel types [i.e., IK(DR) and IM]. Outward currents were evoked by stepping to +50 mV from a -90-mV holding potential in the absence and presence of 500 µM TEA. The net TEA-sensitive current, and thus the current mediated by BK channels, was determined by subtracting the current remaining after TEA application from that observed under control conditions (absence of TEA). Two distinct TEA-sensitive currents, which differed in their time-dependent inactivation kinetics, were seen in our experiments. These currents were expressed in different populations of neurons, with the fast inactivating current (BKi) being expressed in six of 10 cells and the slowly inactivating or noninactivating currents (BKs) being expressed in the remaining four cells. Currents representative of each BK channel subtype are shown in Fig. 7, A and B. Both the rapidly decaying and the slowly decaying TEA-sensitive currents were blocked by 1 mM DTG. Figure 7, C and D, shows bar graphs of the mean peak and sustained current amplitude obtained from the BKi (n = 6) and BKs (n = 4) species, respectively. Both phases of the current were reduced in the two current types when 1 mM of DTG was applied.



View larger version (22K):
[in this window]
[in a new window]
 
Fig. 7. The {sigma} receptor activation blocks BK in rat intracardiac neurons. Traces of BK-mediated currents recorded from two neurons, expressing fast inactivating (A) and slowly inactivating BK channels (B), in the absence (control) and presence of 1 mM DTG (DTG). BK-mediated currents were evoked by step depolarizations to +50 mV from a holding potential of –90 mV and defined as the net TEA-sensitive current. The net TEA-sensitive current was determined by subtracting the outward current recorded in the presence of 500 µM TEA (with or without DTG) from the outward current obtained in the absence of TEA (with or without DTG). Bar graph of the peak and sustained BK current amplitudes recorded in the absence (control) and presence of DTG (DTG; 1 mM) in cells expressing fast-inactivating (C; n = 6) or slowly inactivating (D; n = 4) BK channels. Asterisks denote significant difference from control (p < 0.05).

 


    Discussion
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
The results presented here show that in neonatal rat intracardiac neurons activation of {sigma}-1 receptors reversibly inhibited IK(DR),IK(Ca), and IM through a pathway that involved neither a diffusible cytosolic second messenger nor a G protein. Furthermore, activation of {sigma} receptors resulted in the depolarization of the neurons and depression of neuroexcitability.

Studies in our laboratory have demonstrated that {sigma}-1 receptors are expressed in parasympathetic intracardiac neurons, but the cellular function of these receptors remained unknown. Whereas {sigma}-2 receptors in these cells couple to Ca2+ channels, {sigma}-1 receptors modulate the function of various K+ channels in these neurons. Although the modulation of Ca2+ channels in intracardiac neurons by neurotransmitters is well documented, less is known about the regulation of K+ channels in these cells (Adams and Cuevas, 2004Go). Activation of M1 muscarinic receptors in neonatal rat intracardiac neurons has been shown to block IM in these cells (Cuevas et al., 1997Go), and activation of a prostaglandin E2 receptor inhibits a small-conductance IK(Ca) in adult guinea pig intracardiac neurons (Jelson et al., 2003Go). The {sigma}-1 receptor activation, however, inhibits multiple K+ channels subtypes in intracardiac neurons. The modulation of K+ channels by {sigma} receptors has been reported in mouse sympathetic neurons, frog melanotrophs, and mouse neurohypophysial nerve terminals (Kennedy and Henderson, 1990Go; Soriani et al., 1998Go, 1999aGo,bGo; Wilke et al., 1999Go). The K+ channel types that have been shown to be modulated by {sigma} receptor activation include A-type K+ channels (IA), IK(Ca), IK(DR), and IM, and multiple K+ channels types are frequently affected in individual cells (Soriani et al.,1999aGo,bGo; Wilke et al.,1999Go). All of these K+ channel subtypes, except A-type K+ channels, which are not expressed in intracardiac neurons, were shown to be affected by {sigma} receptor activation in our study.

Although {sigma} receptors have been shown to block K+ channels in native cells, the {sigma} receptor subtype mediating these effects has not been definitively identified. The rank-order potency for IK inhibition by {sigma} ligands reported here, haloperidol > (+)-pentazocine > ibogaine > DTG, suggests that the effect is mediated by {sigma}-1 receptor activation. In contrast, the rank-order potency for {sigma} ligand inhibition of Ca2+ channels in intracardiac neurons is haloperidol > ibogaine > (+)-pentazocine > DTG, which is consistent with a {sigma}-2 receptor-mediated effect. The IC50 values for the various {sigma} ligands tested here are in agreement with those reported in the literature for modulations of voltage-gated K+ channels. For example, in frog pituitary melanotrophs, (+)-pentazocine inhibited delayed outwardly rectifying K+ channels with an IC50 of 37 µM, compared with the IC50 of 42 µM reported here. Similarly, 100 µM (+)-SKF-10,047 blocked approximately 50% of the voltage-activated K+ currents recorded in neurohypophysial nerve terminals (Wilke et al., 1999Go). Thus, {sigma}-1 receptors are likely to be responsible for inhibition of K+ channels in intracardiac neurons and in other native cells studied. The conclusion that {sigma} receptors mediate the inhibition of IK by {sigma} ligands in intracardiac neurons is strengthened by the observation that metaphit, an irreversible, antagonist of {sigma} receptors, blocks the effects of DTG on IK in these cells.

Considerable controversy exists as to the mechanisms by which {sigma} receptors modulate K+ channels. In frog pituitary melanotrophs, cell dialysis with GTP-{beta}-S and preincubation in cholera toxin were shown to inhibit {sigma} receptor effects on IA and IK(DR) (Soriani et al., 1999aGo,bGo), suggesting that {sigma} receptors couple to the K+ channels via a G protein. G proteins have also been implicated in both {sigma} receptor-mediated activation of phospholipase C and regulation of Ca2+ release from intracellular stores (Morin-Surun et al., 1999Go; Hayashi et al., 2000Go). However, neither cell dialysis nor application of intracellular GTP-{beta}-S blocked the inhibition of IK by {sigma}-1 receptors in intracardiac neurons. Thus, {sigma} receptors couple to K+ channels in these cells via a membrane-delimited signal transduction cascade that does not involve a G protein. Our observation is in agreement with the direct protein-protein interaction between {sigma}-1 receptors and K+ channels shown by Jackson and colleagues (Lupardus et al., 2000Go; Aydar et al., 2002Go).

The net effect of {sigma} receptor modulation of ion channels in intracardiac neurons at rest is a depolarization of the membrane potential. We have previously shown that the IM contributes to the resting membrane potential of intracardiac neurons and that inhibition of this channel depolarizes the cells (Cuevas et al., 1997Go). Given that application of DTG blocks IM, {sigma} receptor modulation of these channels likely accounts for the depolarizations reported here. Further support for this conclusion comes from the fact that neither inhibition IK(DR) nor IK(Ca) has been linked to changes in the resting membrane potential of these neurons (Xu and Adams, 1992Go; Hogg et al., 1999Go; Jelson et al., 2003Go). Inhibition of voltage gated Ca2+ channels by {sigma}-2 receptor activation is also unlikely to account for this depolarization since removal of extracellular Ca2+ does not alter the resting membrane potential of these cells (DeHaven and Cuevas, 2004Go).

The block of IK by {sigma} receptors in intracardiac neuron is associated with decreased action potential firing, whereas previous studies have shown that {sigma} receptor block of IK enhances neuroexcitability (Soriani et al., 1998Go). Our laboratory has shown that inhibition of IM is associated with increased excitability of intracardiac neurons (Cuevas et al., 1997Go), and thus {sigma} receptor modulation of non-IM K+ channels must be responsible for the decreased excitability observed. The depressed neuroexcitability reported here likely results from modulation of IK(DR) by {sigma} receptors. Verapamil has been shown to convert tonic and adapting intracardiac neurons into phasic neurons via a direct block of IK(DR) (Hogg et al., 1999Go). However, high concentrations of verapamil failed to abolish action potential firing in intracardiac neurons, whereas high concentrations of {sigma} ligands completely blocked the genesis of action potentials in these cells. The concentrations of (+)-pentazocine (50 µM) and ibogaine (200 µM) required to appreciably decrease action potential firing and alter the action potential configuration in our study suggest that the effects of {sigma} ligands on the active membrane properties of these cells are primarily mediated by {sigma}-1 receptors. However, inhibition of voltage-activated K+ channels alone cannot explain the complete block of action potential firing at high concentrations of {sigma} ligands, and thus {sigma} receptors are likely to affect other channel types that regulate action potential firing (e.g., voltage-gated sodium channels).

The inhibition of IK(Ca) by {sigma} receptors is also likely to contribute to changes in the active membrane properties of intracardiac neurons. Two types of {sigma} receptor-regulated BK currents were found in rat intracardiac neurons, one which exhibited rapid time-dependent inactivation, BKi, and a second that showed little or no inactivation, BKs. The presence of distinct subpopulations of BK channels with dissimilar inactivation kinetics has been reported in rat adrenal chromaffin cells (Solaro et al., 1995Go). The inhibition of BK currents by {sigma} receptors would account, at least in part, for the increase in action potential duration and decrease in AHPs reported here, since inhibition of BK by 200 µM TEA produces similar effects on the action potentials of these cells (Franciolini et al., 2001Go). Although inhibition of voltage-gated Ca2+ channels may contribute to the decrease in IK(Ca) amplitude observed in our studies, it is unlikely to exclusively account for the block of BK channels observed here. Evidence for this conclusion comes from the fact that concentrations of Cd2+ (100 µM) that inhibit all Ca2+ channels in these neurons (Cuevas and Adams, 1997Go) fail to eliminate the AHPs in these cells (Franciolini et al., 2001Go). Furthermore, in our study, 100 µMCd2+ blocked <5% of IK, whereas 500 µM TEA or Ca2+-free extracellular solution blocked ~25% of IK (data not shown). Together, these data suggest that {sigma}-1 receptors are likely having a direct effect on BK channels in intracardiac neurons. However, {sigma} receptor modulation of other mechanisms of Ca2+ entry or homeostasis must also be examined to confirm a direct effect on IK(Ca).

There has been considerable speculation about the role of {sigma} receptors in the cardiovascular system. Although the endogenous ligand responsible for activating {sigma} receptors under physiological and pathophysiological conditions remains to be determined, there are data suggesting that some putative {sigma} receptor ligands may affect the heart and coronary vasculature. For example, pregnenolone, a putative {sigma} ligand (Maurice et al., 2001Go), increases heart rate and cardiac output in anesthetized dogs (Hogskilde et al., 1991Go). Such effects may in part be due to activation of {sigma} receptors on intracardiac neurons. Similarly, various drugs that act on {sigma} receptors, such as haloperidol, have significant effects on the heart (Monassier and Bousquet, 2002Go). Our observations raise the possibility that the cardiovascular effects of these compounds may be mediated by their modulation of the electrical activity of intrinsic cardiac neurons. In conclusion, stimulation of {sigma}-1 receptors inhibits multiple voltage-gated K+ channel subtypes and depresses excitability in intracardiac neurons. Thus, activation of {sigma}-1 receptors in these cells is likely to attenuate parasympathetic input to the heart, and consequently, to affect cardiovascular function.


    Acknowledgements
 
We thank Dr. Christopher Katnik, Wayne I. DeHaven, and Nivia Cuevas for comments on a draft of this manuscript.


    Footnotes
 
This study was supported by National Institutes of Health Grant R01 HL63247 (to J.C.) and American Heart Association Florida/Puerto Rico Affiliate Awards (grant-in-aid to J.C. and Predoctoral Fellowship to H.Z.). A preliminary report of some of these results has been presented in abstract form (Zhang and Cuevas, 2003Go).

Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.

doi:10.1124/jpet.105.084152.

ABBREVIATIONS: (+)-SKF-10,047, 2S-(2a,6a,11R*]-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(2-propenyl)-2,6-methano-3-benzazocin-8-ol hydrochloride; DTG, 1,3-di-O-tolyguanidin; Kv, voltage-activated K+ channel; IK, voltage-activated K+ channel current; K(DR), delayed outwardly rectifying K+ channel; IM, M-current; GDP-{beta}-S, guanosine 5'-O-(2-thiodiphosphate) trilithium salt; PSS, physiological saline solution; TTX, tetrodotoxin; GTP, GTP lithium salt; TEA, tetraethylammonium chloride; BK, large conductance K(Ca) channel; AHP, afterhyperpolarization; K(Ca), Ca2+-sensitive K+ channel; SK, small conductance K(Ca) channel; IK, intermediate conductance K(Ca) channel; BKi, fast inactivating BK current; BKs, noninactivating BK current; SM-21, (±)-tropanyl 2-(4-chlorophenoxy)butanoate maleate; BD-1047, N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(dimethylamino)ethylamine dihydrobromide; BD-1063, 1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine dihydrochloride.

Address correspondence to: Dr. Javier Cuevas, Department of Pharmacology and Therapeutics, University of South Florida College of Medicine, 12901 Bruce B. Downs Blvd., MDC 9, Tampa, FL 33612-4799. E-mail: jcuevas{at}hsc.usf.edu


    References
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

Adams DJ and Cuevas J (2004) Electrophysiological properties of cardiac neurons- the foundation of neurocardiology, in Basic and Clinical Neurocardiology (Armour JA and Ardell JL eds) pp 1-60, Oxford University Press, New York.

Aydar E, Palmer CP, Klyachko VA, and Jackson MB (2002) The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 34: 399-410.[CrossRef][Medline]

Bluth LS, Rice KC, Jacobson AE, and Bowen WD (1989) Acylation of sigma receptors by metaphit, an isothiocyanate derivative of phencyclidine. Eur J Pharmacol 161: 273-277.[CrossRef][Medline]

Cuevas J and Adams DJ (1994) Local anaesthetic blockade of neuronal nicotinic ACh receptor-channels in rat parasympathetic ganglion cells. Br J Pharmacol 111: 663-672.[Medline]

Cuevas J and Adams DJ (1997) M4 muscarinic receptor activation modulates calcium channel currents in rat intracardiac neurons. J Neurophysiol 78: 1903-1912.[Abstract/Free Full Text]

Cuevas J, Harper AA, Trequattrini C, and Adams DJ (1997) Passive and active membrane properties of isolated rat intracardiac neurons: regulation by H- and M-currents. J Neurophysiol 78: 1890-1902.[Abstract/Free Full Text]

DeHaven WI and Cuevas J (2004) VPAC receptor modulation of neuroexcitability in intracardiac neurons: dependence on intracellular calcium mobilization and synergistic enhancement by PAC1 receptor activation. J Biol Chem 279: 40609-40621.[Abstract/Free Full Text]

Ela C, Barg J, Vogel Z, Hasin Y, and Eilam Y (1994) Sigma receptor ligands modulate contractility, Ca++ influx and beating rate in cultured cardiac myocytes. J Pharmacol Exp Ther 269: 1300-1309.[Abstract/Free Full Text]

Franciolini F, Hogg R, Catacuzzeno L, Petris A, Trequattrini C, and Adams DJ (2001) Large-conductance calcium-activated potassium channels in neonatal rat intracardiac ganglion neurons. Pflugers Arch 441: 629-638.[CrossRef][Medline]

Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, and Glossmann H (1996) Purification, molecular cloning and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci USA 93: 8072-8077.[Abstract/Free Full Text]

Hayashi T, Maurice T, and Su TP (2000) Ca(2+) signaling via {sigma}(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration. J Pharmacol Exp Ther 293: 788-798.[Abstract/Free Full Text]

Hellewell SB and Bowen WD (1990) A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res 527: 244-253.[CrossRef][Medline]

Hogg RC, Trequattrini C, Catacuzzeno L, Petris A, Franciolini F, and Adams DJ (1999) Mechanisms of verapamil inhibition of action potential firing in rat intracardiac ganglion neurons. J Pharmacol Exp Ther 289: 1502-1508.[Abstract/Free Full Text]

Hogskilde S, Wagner J, Strom J, Sjontoft E, Olesen HP, and Bredgaard SM (1991) Cardiovascular effects of pregnenolone emulsion: an experimental study in artificially ventilated dogs. Acta Anaesthesiol Scand 35: 669-675.[Medline]

Jelson GS, DeMasi GM, Sager KL, and Hardwick JC (2003) Modulation of guinea pig intrinsic cardiac neurons by prostaglandins. Am J Physiol 285: R682-R689.

Kennedy C and Henderson G (1990) Inhibition of potassium currents by the sigma receptor ligand (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine in sympathetic neurons of the mouse isolated hypogastric ganglion. Neuroscience 35: 725-733.[CrossRef][Medline]

Lishmanov YB, Maslov LN, Krylatov AV, Ugdyzhekova DS, Gilligan P, and Tam SW (2000) The anti-arrhythmia and proarrhythmia properties of sigma-receptor ligands. Eksp Klin Farmakol 63: 39-43.

Lishmanov YB, Maslov LN, Naryzhnaya NV, and Tam SW (1999) Ligands for opioid and sigma-receptors improve cardiac electrical stability in rat models of post-infarction cardiosclerosis and stress. Life Sci 65: PL13-PL17.[CrossRef][Medline]

Lupardus PJ, Wilke RA, Aydar E, Palmer CP, Chen Y, Ruoho AE, and Jackson MB (2000) Membrane-delimited coupling between sigma receptors and K+ channels in rat neurohypophysial terminals requires neither G-protein nor ATP. J Physiol (Lond) 526: 527-539.[Abstract/Free Full Text]

Maurice T, Urani A, Phan VL, and Romieu P (2001) The interaction between neuroactive steroids and the sigma1 receptor function: behavioral consequences and therapeutic opportunities. Brain Res Rev 37: 116-132.[CrossRef][Medline]

Monassier L and Bousquet P (2002) Sigma receptors: from discovery to highlights of their implications in the cardiovascular system. Fundam Clin Pharmacol 16: 1-8.[CrossRef][Medline]

Morin-Surun MP, Collin T, Denavit-Saubié M, Baulieu EE, and Monnet FP (1999) Intracellular {sigma}1 receptor modulates phospholipase C and protein kinase C activities in the brainstem. Proc Nat Acad Sci USA 14: 8196-8199.

Narita N, Hashimoto K, Tomitaka S, and Minabe Y (1996) Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain. Eur J Pharmacol 307: 117-119.[CrossRef][Medline]

Novakova M, Ela C, Barg J, Vogel Z, Hasin Y, and Eilam Y (1995) Inotropic action of sigma receptor ligands in isolated cardiac myocytes from adult rats. Eur J Pharmacol 286: 19-30.[CrossRef][Medline]

Solaro CR, Prakriya M, Ding JP, and Lingle CJ (1995) Inactivating and noninactivating Ca(2+)- and voltage-dependent K+ current in rat adrenal chromaffin cells. J Neurosci 15: 6110-6123.[Abstract]

Soriani O, Foll FL, Roman F, Monnet FP, Vaudry H, and Cazin L (1999a) A-current down-modulated by sigma receptor in frog pituitary melanotrope cells through a G protein-dependent pathway. J Pharmacol Exp Ther 289: 321-328.[Abstract/Free Full Text]

Soriani O, Le Foll F, Galas L, Roman F, Vaudry H, and Cazin L (1999b) The sigma-ligand (+)-pentazocine depresses M current and enhances calcium conductances in frog melanotrophs. Am J Physiol 277: E73-E80.

Soriani O, Vaudry H, Mei YA, Roman F, and Cazin L (1998) Sigma ligands stimulate the electrical activity of frog pituitary melanotrope cells through a G-protein-dependent inhibition of potassium conductances. J Pharmacol Exp Ther 286: 163-171.[Abstract/Free Full Text]

Snyder SH and Largent BL (1989) Receptor mechanisms in antipsychotic drug action: focus on sigma receptors. J Neuropsychiatry Clin Neurosci 1: 7-15.[Abstract/Free Full Text]

Su TP (1982) Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. J Pharmacol Exp Ther 223: 284-290.[Abstract/Free Full Text]

Ujike H, Kuroda S, and Otsuki S (1996) Sigma receptor antagonists block the development of sensitization to cocaine. Eur J Pharmacol 296: 123-128.[CrossRef][Medline]

Wallace DJ, Chen C, and Marley PD (2002) Histamine promotes excitability in bovine adrenal chromaffin cells by inhibiting an M-current. J Physiol (Lond) 540: 921-939.[Abstract/Free Full Text]

Wilke RA, Lupardus PJ, Grandy DK, Rubinstein M, Low MJ, and Jackson MB (1999) K+ channel modulation in rodent neurohypophysial nerve terminals by sigma receptors and not by dopamine receptors. J Physiol (Lond) 517: 391-406.[Abstract/Free Full Text]

Wu KM and Martin WR (1989) Cardiovascular and respiratory effects of an opioid kappa agonist ethylketazocine and sigma agonist N-allylnormetazocine in acutely decerebrated dogs. Pharmacol Biochem Behav 34: 405-411.[CrossRef][Medline]

Xi-Moy SX and Dun NJ (1995) Potassium currents in adult rat intracardiac neurones. J Physiol (Lond) 486: 15-31.[Medline]

Xu ZJ and Adams DJ (1992) Voltage-dependent sodium and calcium currents in cultured parasympathetic neurones from rat intracardiac ganglia. J Physiol (Lond) 456: 425-441.[Abstract/Free Full Text]

Zambon AC, De Costa BR, Kanthasamy AG, Nguyen BQ, and Matsumoto RR (1997) Subchronic administration of N-[2-(3,4-dichlorophenyl) ethyl]-N-methyl-2-(dimethylamino) ethylamine (BD1047) alters sigma 1 receptor binding. Eur J Pharmacol 324: 39-47.[CrossRef][Medline]

Zhang H and Cuevas J (2002) Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons. J Neurophysiol 87: 2867-2879.[Abstract/Free Full Text]

Zhang H and Cuevas J (2003) Sigma receptors activation depresses delayed outwardly rectifying K+ channels in rat intracardiac neurons (Abstract). Soc Neurosci Abstr 831.13. 33rd Annual Society for Neuroscience Meeting; 2003 Nov 8–12; New Orleans, LA.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
L. Monassier, B. Manoury, C. Bellocq, J. Weissenburger, H. Greney, D. Zimmermann, J.-D. Ehrhardt, P. Jaillon, I. Baro, and P. Bousquet
{sigma}2-Receptor Ligand-Mediated Inhibition of Inwardly Rectifying K+ Channels in the Heart
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 341 - 350.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Katnik, W. R. Guerrero, K. R. Pennypacker, Y. Herrera, and J. Cuevas
Sigma-1 Receptor Activation Prevents Intracellular Calcium Dysregulation in Cortical Neurons during in Vitro Ischemia
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1355 - 1365.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.084152v1
313/3/1387    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, H.
Right arrow Articles by Cuevas, J.